Top Key Companies for Pharmaceutical Excipients for Non-injection Market: Dow, Nippon Fine Chemical, Nanjing Well Pharmaceutical, Jiangsu Maxim Biological, NOF, Croda, Jiangsu Poly Pharmaceutical, Er Kang Pharmaceutical, Guangzhou Hanfang Pharmaceutical, Pfanstiehl, Xi'an Libang Pharmaceutical, Zhejiang Tianyushan Medicinal Oil.
Global Pharmaceutical Excipients for Non-injection Market Size was estimated at USD 3128.6 million in 2022 and is projected to reach USD 3801.47 million by 2028, exhibiting a CAGR of 3.3% during the forecast period.
Global Pharmaceutical Excipients for Non-injection Market Overview And Scope:
The Global Pharmaceutical Excipients for Non-injection Market Report 2023 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Pharmaceutical Excipients for Non-injection utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Pharmaceutical Excipients for Non-injection Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Excipients for Non-injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pharmaceutical Excipients for Non-injection market.
Global Pharmaceutical Excipients for Non-injection Market Segmentation
By Type, Pharmaceutical Excipients for Non-injection market has been segmented into:
Binders
Disintegrants
Lubricants
Fillers
Others
By Application, Pharmaceutical Excipients for Non-injection market has been segmented into:
Tablets
Capsules
Oral Liquids
Others
Regional Analysis of Pharmaceutical Excipients for Non-injection Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Pharmaceutical Excipients for Non-injection Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Pharmaceutical Excipients for Non-injection market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Pharmaceutical Excipients for Non-injection market.
Top Key Companies Covered in Pharmaceutical Excipients for Non-injection market are:
Dow
Nippon Fine Chemical
Nanjing Well Pharmaceutical
Jiangsu Maxim Biological
NOF
Croda
Jiangsu Poly Pharmaceutical
Er Kang Pharmaceutical
Guangzhou Hanfang Pharmaceutical
Pfanstiehl
Xi'an Libang Pharmaceutical
Zhejiang Tianyushan Medicinal Oil
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Pharmaceutical Excipients for Non-injection Market by Type
5.1 Pharmaceutical Excipients for Non-injection Market Overview Snapshot and Growth Engine
5.2 Pharmaceutical Excipients for Non-injection Market Overview
5.3 Binders
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2030F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Binders: Geographic Segmentation
5.4 Disintegrants
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2030F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Disintegrants: Geographic Segmentation
5.5 Lubricants
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2030F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Lubricants: Geographic Segmentation
5.6 Fillers
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2030F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Fillers: Geographic Segmentation
5.7 Others
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2016-2030F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Others: Geographic Segmentation
Chapter 6: Pharmaceutical Excipients for Non-injection Market by Application
6.1 Pharmaceutical Excipients for Non-injection Market Overview Snapshot and Growth Engine
6.2 Pharmaceutical Excipients for Non-injection Market Overview
6.3 Tablets
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2030F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Tablets: Geographic Segmentation
6.4 Capsules
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2030F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Capsules: Geographic Segmentation
6.5 Oral Liquids
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2030F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Oral Liquids: Geographic Segmentation
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2030F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Pharmaceutical Excipients for Non-injection Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Pharmaceutical Excipients for Non-injection Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Pharmaceutical Excipients for Non-injection Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 DOW
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 NIPPON FINE CHEMICAL
7.4 NANJING WELL PHARMACEUTICAL
7.5 JIANGSU MAXIM BIOLOGICAL
7.6 NOF
7.7 CRODA
7.8 JIANGSU POLY PHARMACEUTICAL
7.9 ER KANG PHARMACEUTICAL
7.10 GUANGZHOU HANFANG PHARMACEUTICAL
7.11 PFANSTIEHL
7.12 XI'AN LIBANG PHARMACEUTICAL
7.13 ZHEJIANG TIANYUSHAN MEDICINAL OIL
Chapter 8: Global Pharmaceutical Excipients for Non-injection Market Analysis, Insights and Forecast, 2016-2030
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Binders
8.2.2 Disintegrants
8.2.3 Lubricants
8.2.4 Fillers
8.2.5 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Tablets
8.3.2 Capsules
8.3.3 Oral Liquids
8.3.4 Others
Chapter 9: North America Pharmaceutical Excipients for Non-injection Market Analysis, Insights and Forecast, 2016-2030
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Binders
9.4.2 Disintegrants
9.4.3 Lubricants
9.4.4 Fillers
9.4.5 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Tablets
9.5.2 Capsules
9.5.3 Oral Liquids
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Pharmaceutical Excipients for Non-injection Market Analysis, Insights and Forecast, 2016-2030
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Binders
10.4.2 Disintegrants
10.4.3 Lubricants
10.4.4 Fillers
10.4.5 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Tablets
10.5.2 Capsules
10.5.3 Oral Liquids
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Pharmaceutical Excipients for Non-injection Market Analysis, Insights and Forecast, 2016-2030
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Binders
11.4.2 Disintegrants
11.4.3 Lubricants
11.4.4 Fillers
11.4.5 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Tablets
11.5.2 Capsules
11.5.3 Oral Liquids
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Pharmaceutical Excipients for Non-injection Market Analysis, Insights and Forecast, 2016-2030
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Binders
12.4.2 Disintegrants
12.4.3 Lubricants
12.4.4 Fillers
12.4.5 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Tablets
12.5.2 Capsules
12.5.3 Oral Liquids
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Pharmaceutical Excipients for Non-injection Market Analysis, Insights and Forecast, 2016-2030
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Binders
13.4.2 Disintegrants
13.4.3 Lubricants
13.4.4 Fillers
13.4.5 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Tablets
13.5.2 Capsules
13.5.3 Oral Liquids
13.5.4 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Pharmaceutical Excipients for Non-injection Market Analysis, Insights and Forecast, 2016-2030
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Binders
14.4.2 Disintegrants
14.4.3 Lubricants
14.4.4 Fillers
14.4.5 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Tablets
14.5.2 Capsules
14.5.3 Oral Liquids
14.5.4 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Pharmaceutical Excipients for Non-injection Scope:
|
Report Data
|
Pharmaceutical Excipients for Non-injection Market
|
|
Pharmaceutical Excipients for Non-injection Market Size in 2025
|
USD XX million
|
|
Pharmaceutical Excipients for Non-injection CAGR 2025 - 2032
|
XX%
|
|
Pharmaceutical Excipients for Non-injection Base Year
|
2024
|
|
Pharmaceutical Excipients for Non-injection Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Dow, Nippon Fine Chemical, Nanjing Well Pharmaceutical, Jiangsu Maxim Biological, NOF, Croda, Jiangsu Poly Pharmaceutical, Er Kang Pharmaceutical, Guangzhou Hanfang Pharmaceutical, Pfanstiehl, Xi'an Libang Pharmaceutical, Zhejiang Tianyushan Medicinal Oil.
|
|
Key Segments
|
By Type
Binders
Disintegrants
Lubricants
Fillers
Others
By Applications
Tablets
Capsules
Oral Liquids
Others
|
